Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial. (Record no. 25432733)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02194 a2200637 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517062602.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201604s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1539-3704 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.7326/M15-1014 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Pianko, Stephen |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160407 |
| 245 00 - TITLE STATEMENT | |
| Title | Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of internal medicine |
| Date of publication, distribution, etc. | Dec 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 809-17 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carbamates |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepacivirus |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis C, Chronic |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heterocyclic Compounds, 4 or More Rings |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liver Cirrhosis |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA, Viral |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ribavirin |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sofosbuvir |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Flamm, Steven L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shiffman, Mitchell L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kumar, Sonal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Strasser, Simone I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dore, Gregory J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McNally, John |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brainard, Diana M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Han, Lingling |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Doehle, Brian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mogalian, Erik |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McHutchison, John G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rabinovitz, Mordechai |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Towner, William J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gane, Edward J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stedman, Catherine A M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reddy, K Rajender |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roberts, Stuart K |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of internal medicine |
| Related parts | vol. 163 |
| -- | no. 11 |
| -- | p. 809-17 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.7326/M15-1014">https://doi.org/10.7326/M15-1014</a> |
| Public note | Available from publisher's website |
No items available.